MX2023000423A - Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades. - Google Patents

Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades.

Info

Publication number
MX2023000423A
MX2023000423A MX2023000423A MX2023000423A MX2023000423A MX 2023000423 A MX2023000423 A MX 2023000423A MX 2023000423 A MX2023000423 A MX 2023000423A MX 2023000423 A MX2023000423 A MX 2023000423A MX 2023000423 A MX2023000423 A MX 2023000423A
Authority
MX
Mexico
Prior art keywords
trehalose
ailment
prebiotic
inhibiting
inducing microorganisms
Prior art date
Application number
MX2023000423A
Other languages
English (en)
Inventor
Mingming Pu
Chung-Ching Chu
Qin Yin
Xueyang Yue
Original Assignee
Unilever Ip Holdings B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Ip Holdings B V filed Critical Unilever Ip Holdings B V
Publication of MX2023000423A publication Critical patent/MX2023000423A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con un uso novedoso de trehalosa. Más particularmente, la presente invención se relaciona con un uso novedoso de trehalosa para promover la salud del cuero cabelludo. Por lo tanto, la presente invención proporciona la utilización de trehalosa como prebiótico para inhibir los microorganismos inductores de afecciones cuando se aplica sobre una superficie externa del cuerpo humano.
MX2023000423A 2020-07-10 2021-06-11 Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades. MX2023000423A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2020101302 2020-07-10
EP20192342 2020-08-24
PCT/EP2021/065735 WO2022008163A1 (en) 2020-07-10 2021-06-11 Use of trehalose as prebiotic for inhibiting ailment inducing microorganisms

Publications (1)

Publication Number Publication Date
MX2023000423A true MX2023000423A (es) 2023-02-09

Family

ID=76305940

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000423A MX2023000423A (es) 2020-07-10 2021-06-11 Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades.

Country Status (5)

Country Link
US (1) US20230270653A1 (es)
EP (1) EP4178528A1 (es)
CN (1) CN115867347A (es)
MX (1) MX2023000423A (es)
WO (1) WO2022008163A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3202135B2 (ja) * 1994-08-10 2001-08-27 カネボウ株式会社 頭髪化粧料
US20020165168A1 (en) * 1995-12-16 2002-11-07 Joachim Bunger Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
EP1340486A1 (de) * 2002-03-01 2003-09-03 Cognis France S.A. Verwendung von Zuckerestern
EP3143983A1 (en) * 2003-02-13 2017-03-22 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo External dermatological formulation comprising saccharide derivative of alpha, alpha-trehalose
DE102004032734A1 (de) 2004-03-18 2005-10-06 Henkel Kgaa Präbiotisch wirksame Substanzen für Deodorantien
WO2013070893A1 (en) 2011-11-08 2013-05-16 The Procter & Gamble Company Method of making cosmetic compositions containing a prebiotic
CN103250880B (zh) * 2013-06-03 2015-03-04 史莹华 一种海藻糖—蒙脱石纳米复合物作为饲料添加剂的新应用
FR3064473B1 (fr) * 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas Ingredient protecteur de l'equilibre de la flore microbienne cutanee et/ou mucosale
KR101953375B1 (ko) * 2017-11-20 2019-02-28 고려대학교 산학협력단 다양하고 신규한 퓨코실 올리고당의 제조법 및 이의 용도

Also Published As

Publication number Publication date
EP4178528A1 (en) 2023-05-17
WO2022008163A1 (en) 2022-01-13
US20230270653A1 (en) 2023-08-31
CN115867347A (zh) 2023-03-28

Similar Documents

Publication Publication Date Title
PH12019502793A1 (en) Aadc polynucleotides for the treatment of parkinson`s disease
TWD192896S (zh) 按摩器
PH12015502788A1 (en) Antibody formulations and methods
EA201891224A1 (ru) Способы и системы для предоставления стимулов для головного мозга
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
MX2018012655A (es) Compuestos y metodos para tratamiento de afecciones neurologicas y cardiovasculares.
MX2009013353A (es) Compuestos activadores de telomerasa y metodos para su uso.
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
MX2017014245A (es) Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas.
MY161197A (en) Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
PH12019500643A1 (en) Antibodies that bind interleukin-2 and uses thereof
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
WO2018178243A3 (en) Dihydrotetrabenazine for use in the treatment a movement disorder
MX2021003515A (es) Compuestos polimorficos y usos de los mismos.
PH12018501665A1 (en) Process for preparing a silicone elastomer with hydrophilic actives and a personal care composition containing the elastomer
MX366927B (es) Composición para cuidado de la piel que comprende nitruro de boro turboestrático.
NZ745185A (en) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
JOP20210008A1 (ar) أنواع أبيراز مذابة، وطرق لاستخدامها
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
MX2022005084A (es) Formas sólidas de un modulador del receptor s1p a.
MX2023000423A (es) Uso de trehalosa como prebiotico para inhibir los microorganismos inductores de enfermedades.
WO2020109233A3 (en) Trmt2a inhibitors for use in the treatment of polyglutamine diseases
EP4017880A4 (en) USE OF BRAZIKUMAB TO TREAT CROHN'S DISEASE